Biosimilars ∙ Regulatory Frameworks for Marketing Authorisation of Biosimilars: Where Do We Go From Here?
Authors:
- Evelien MoorkensEMEvelien Moorkens
- Arnold G VultoAVArnold G Vulto
- Isabelle HuysIHIsabelle Huys
- 1 January 2018
- journal article
- Published by Lexxion Verlag in European Pharmaceutical Law Review
- Vol. 2 (3) , 149-154